Reply

Natasha K Martin^{1

2}, Peter Vickerman², Matthew Hickman²

Affiliations

¹ Division of Global Public Health, University of California, San Diego, San Diego, CA.
² School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.

Comment

Natasha K Martin et al. Hepatology. 2016 Nov.

. 2016 Nov;64(5):1822-1823.

doi: 10.1002/hep.28612. Epub 2016 May 28.

Natasha K Martin^{1

2}, Peter Vickerman², Matthew Hickman²

¹ Division of Global Public Health, University of California, San Diego, San Diego, CA.
² School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.

No abstract available

Comment on

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis.
Martin NK, Vickerman P, Brew IF, Williamson J, Miners A, Irving WL, Saksena S, Hutchinson SJ, Mandal S, O'Moore E, Hickman M. Martin NK, et al. Hepatology. 2016 Jun;63(6):1796-808. doi: 10.1002/hep.28497. Epub 2016 Mar 22. Hepatology. 2016. PMID: 26864802 Free PMC article.
Hepatitis C management in prisons: An insight into daily clinical practice in three major Italian correctional houses.
Foschi A, Casana M, Radice A, Ranieri R, d'Arminio Monforte A. Foschi A, et al. Hepatology. 2016 Nov;64(5):1821-1822. doi: 10.1002/hep.28609. Epub 2016 May 31. Hepatology. 2016. PMID: 27118063 No abstract available.